Reader's View: Protect Canadian prescription drug sales
This bill could shut down access to affordable drugs and hurt Minnesota seniors in particular.
U.S. Sen. Amy Klobuchar has been a champion for lower drug costs. So why is she co-sponsoring a Senate bill backed by Big Pharma?
The DRUGS Act states that it is, "To amend the Federal Food, Drug, and Cosmetic Act to provide a process to lock and suspend domain names used to facilitate the online sale of drugs illegally, and for other purposes.”
Under the Prescription Drug Marketing Act of 1987, technically, it is illegal for anyone other than the original manufacturer to bring prescription drugs into the U.S. At present, officials look the other way for small quantities. If enforced, the new bill could close access for U.S. citizens to all Canadian pharmacy websites. Why not include legalizing purchases of Canadian drugs in the bill? Because Big Pharma would not approve.
The pretense of S.3399 is to curb opioid sales. But the bill makes no distinction between licensed pharmacies that don’t even sell opioids and rogue pharmacies. The bill does not mention fentanyl or opioids.
Klobuchar has been lead author of the Safe and Affordable Drugs from Canada Act. This bill could shut down access to affordable drugs and hurt Minnesota seniors in particular.
Please contact Sen. Klobuchar and ask her to rewrite this bill to make Canadian drug purchases legal and to go after illegal opioid sales. As written, it is just another attempt by Big Pharma to control drug prices.
Mary Arps Thompson
Readers' View and Local Views
Letters are limited to 300 words, must be the original work of the author and must be exclusive to the News Tribune. Letters are edited for style, space, accuracy and civility.
Letter writers are limited to one published submission every 30 days.
With rare exceptions, the News Tribune does not publish poetry; letters that are anonymous, libelous or attack other writers; consumer-complaint letters; thank-you letters; or letters generated by political or special-interest campaigns.
We will consider exclusive Local View columns of 600 words or fewer. Authors should possess unique insights, and their commentaries should demonstrate greater knowledge of their subject than letters.
Email submissions to: firstname.lastname@example.org
Mail to: Readers' Views, Duluth News Tribune, 424 W. First St., Duluth, MN 55802.
Fax to: 218-720-5120.
Include a full name, address and daytime phone number. Only names and hometowns will be published.